These are notes on the tear sheet from the Tech Ethics workshop No Better Time Conference at the University of New Hampshire, July 9-11 co-sponsored by The Democracy Imperative and the Deliberative Democracy Consortium. More notes about this conference on the No Better Time wiki.

These are notes on the tear sheet from the Tech Ethics workshop No Better Time Conference at the University of New Hampshire, July 9-11 co-sponsored by The Democracy Imperative and the Deliberative Democracy Consortium. More notes about this conference on the No Better Time wiki.

These are notes on the tear sheet from the Tech Ethics workshop No Better Time Conference at the University of New Hampshire, July 9-11 co-sponsored by The Democracy Imperative and the Deliberative Democracy Consortium. More notes about this conference on the No Better Time wiki.

Elizabeth Holmes’ rise to prominence was as swift as it was remarkable. As the founder and CEO of Theranos, she captured the world’s attention with her ambitious vision of transforming the healthcare industry. Her mission was to revolutionize blood testing by offering quick and affordable tests with just a single drop of blood. This groundbreaking idea made her one of Silicon Valley’s brightest stars, and for a time, she was hailed as the youngest self-made female billionaire.

The image of Holmes in her iconic black turtleneck became synonymous with her brand—projecting confidence, determination, and a commitment to changing the world. But behind the image was a complex story that would soon unravel. As Theranos grew, so did the questions about the accuracy and reliability of its technology.

Journalists and regulators began to investigate, leading to revelations that Theranos had misled investors, doctors, and patients about its capabilities.

Despite her vision and the excitement surrounding Theranos, Holmes' story is a cautionary tale about the dangers of overpromising in industries where people's health is at stake. The collapse of her company in 2018 sent shockwaves through the tech and medical worlds, serving as a reminder of the importance of transparency and ethical responsibility.

Elizabeth Holmes' fall from grace was as dramatic as her rise. Once celebrated as a trailblazer, she was later charged with fraud and became a symbol of Silicon Valley's darker side, where ambition sometimes overtakes ethics. Yet, her story also highlights the immense pressures faced by young entrepreneurs to deliver results and meet high expectations.

Holmes' legacy remains controversial. To some, she is a symbol of unchecked ambition, while to others, she is a figure who dared to dream big but lost her way. Her journey offers valuable lessons about leadership, ethics, and the complexities of innovation in the modern world.

For more information about Elizabeth Holmes: www.calameo.com/books/007555329b196ea15d914

These are notes on the tear sheet from the Tech Ethics workshop No Better Time Conference at the University of New Hampshire, July 9-11 co-sponsored by The Democracy Imperative and the Deliberative Democracy Consortium. More notes about this conference on the No Better Time wiki.

These are notes on the tear sheet from the Tech Ethics workshop No Better Time Conference at the University of New Hampshire, July 9-11 co-sponsored by The Democracy Imperative and the Deliberative Democracy Consortium. More notes about this conference on the No Better Time wiki.

Exploring the balance between innovation and privacy in gait recognition technology. How do we protect our steps in a digital world?

identityherald.com/privacy-concerns-in-gait-recognition/

#GaitRecognition #PrivacyMatters #TechEthics #DataSecurity

Exploring #BrainwaveBiometrics: The future of authentication meets profound ethical dilemmas. Can we balance innovation with privacy?

identityherald.com/ethical-use-of-brainwave-biometrics/

Dive into the discussion with Bahaa Abdul Hadi on #IdentityHerald. #Neuroethics #TechEthics